nodes	percent_of_prediction	percent_of_DWPC	metapath
Amantadine—DDC—Amino acid and derivative metabolism—PSPH—ocular cancer	0.0329	0.0329	CbGpPWpGaD
Amantadine—GRIN2C—Alzheimers Disease—GNAQ—ocular cancer	0.0248	0.0248	CbGpPWpGaD
Amantadine—GRIN1—BDNF signaling pathway—CRTC1—ocular cancer	0.0246	0.0246	CbGpPWpGaD
Amantadine—GRIN1—Spinal Cord Injury—E2F5—ocular cancer	0.024	0.024	CbGpPWpGaD
Amantadine—GRIN2B—BDNF signaling pathway—CRTC1—ocular cancer	0.024	0.024	CbGpPWpGaD
Amantadine—GRIN2D—Alzheimers Disease—GNAQ—ocular cancer	0.0231	0.0231	CbGpPWpGaD
Amantadine—DDC—Circadian rythm related genes—CRTC1—ocular cancer	0.022	0.022	CbGpPWpGaD
Amantadine—DDC—Circadian rythm related genes—ID2—ocular cancer	0.0196	0.0196	CbGpPWpGaD
Amantadine—GRIN2C—Ras activation uopn Ca2+ infux through NMDA receptor—HRAS—ocular cancer	0.0191	0.0191	CbGpPWpGaD
Amantadine—GRIN2A—Alzheimers Disease—GNAQ—ocular cancer	0.019	0.019	CbGpPWpGaD
Amantadine—GRIN1—Mecp2 and Associated Rett Syndrome—E2F1—ocular cancer	0.0183	0.0183	CbGpPWpGaD
Amantadine—GRIN2D—Ras activation uopn Ca2+ infux through NMDA receptor—HRAS—ocular cancer	0.0178	0.0178	CbGpPWpGaD
Amantadine—GRIN1—Alzheimers Disease—GNAQ—ocular cancer	0.0165	0.0165	CbGpPWpGaD
Amantadine—GRIN2B—Alzheimers Disease—GNAQ—ocular cancer	0.0161	0.0161	CbGpPWpGaD
Amantadine—GRIN2A—Ras activation uopn Ca2+ infux through NMDA receptor—HRAS—ocular cancer	0.0146	0.0146	CbGpPWpGaD
Amantadine—GRIN2B—ErbB4 signaling events—MDM2—ocular cancer	0.0139	0.0139	CbGpPWpGaD
Amantadine—GRIN2C—CREB phosphorylation through the activation of Ras—HRAS—ocular cancer	0.0136	0.0136	CbGpPWpGaD
Amantadine—DDC—Tryptophan metabolism—MDM2—ocular cancer	0.0133	0.0133	CbGpPWpGaD
Amantadine—DDC—Dopaminergic Neurogenesis—TGFB1—ocular cancer	0.013	0.013	CbGpPWpGaD
Amantadine—GRIN1—Ras activation uopn Ca2+ infux through NMDA receptor—HRAS—ocular cancer	0.0127	0.0127	CbGpPWpGaD
Amantadine—GRIN2D—CREB phosphorylation through the activation of Ras—HRAS—ocular cancer	0.0127	0.0127	CbGpPWpGaD
Amantadine—GRIN2B—Ras activation uopn Ca2+ infux through NMDA receptor—HRAS—ocular cancer	0.0124	0.0124	CbGpPWpGaD
Amantadine—ABCB1—HIF-1-alpha transcription factor network—ID2—ocular cancer	0.0116	0.0116	CbGpPWpGaD
Amantadine—GRIN2C—Post NMDA receptor activation events—HRAS—ocular cancer	0.0112	0.0112	CbGpPWpGaD
Amantadine—MAOB—Tryptophan metabolism—MDM2—ocular cancer	0.0112	0.0112	CbGpPWpGaD
Amantadine—GRIN2D—Post NMDA receptor activation events—HRAS—ocular cancer	0.0104	0.0104	CbGpPWpGaD
Amantadine—GRIN2A—CREB phosphorylation through the activation of Ras—HRAS—ocular cancer	0.0104	0.0104	CbGpPWpGaD
Amantadine—GRIN2C—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—ocular cancer	0.0103	0.0103	CbGpPWpGaD
Amantadine—DDC—SIDS Susceptibility Pathways—HDAC1—ocular cancer	0.0101	0.0101	CbGpPWpGaD
Amantadine—DDC—Circadian rythm related genes—GNA11—ocular cancer	0.00981	0.00981	CbGpPWpGaD
Amantadine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CCND3—ocular cancer	0.00968	0.00968	CbGpPWpGaD
Amantadine—GRIN2D—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—ocular cancer	0.0096	0.0096	CbGpPWpGaD
Amantadine—GRIN2A—Reelin signaling pathway—AKT1—ocular cancer	0.00944	0.00944	CbGpPWpGaD
Amantadine—DDC—Circadian rythm related genes—GNAQ—ocular cancer	0.00912	0.00912	CbGpPWpGaD
Amantadine—GRIN1—CREB phosphorylation through the activation of Ras—HRAS—ocular cancer	0.00907	0.00907	CbGpPWpGaD
Amantadine—GRIN1—Spinal Cord Injury—E2F1—ocular cancer	0.0089	0.0089	CbGpPWpGaD
Amantadine—GRIN2B—CREB phosphorylation through the activation of Ras—HRAS—ocular cancer	0.00884	0.00884	CbGpPWpGaD
Amantadine—DRD2—Circadian rythm related genes—CRTC1—ocular cancer	0.00866	0.00866	CbGpPWpGaD
Amantadine—GRIN1—SIDS Susceptibility Pathways—HDAC1—ocular cancer	0.00865	0.00865	CbGpPWpGaD
Amantadine—GRIN2A—Post NMDA receptor activation events—HRAS—ocular cancer	0.00856	0.00856	CbGpPWpGaD
Amantadine—DDC—Circadian rythm related genes—HDAC1—ocular cancer	0.00822	0.00822	CbGpPWpGaD
Amantadine—GRIN2B—Reelin signaling pathway—AKT1—ocular cancer	0.00803	0.00803	CbGpPWpGaD
Amantadine—GRIN2A—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—ocular cancer	0.00788	0.00788	CbGpPWpGaD
Amantadine—DRD2—Circadian rythm related genes—ID2—ocular cancer	0.00772	0.00772	CbGpPWpGaD
Amantadine—GRIN1—Spinal Cord Injury—CDK2—ocular cancer	0.00768	0.00768	CbGpPWpGaD
Amantadine—GRIN1—Post NMDA receptor activation events—HRAS—ocular cancer	0.00746	0.00746	CbGpPWpGaD
Amantadine—GRIN2B—Post NMDA receptor activation events—HRAS—ocular cancer	0.00728	0.00728	CbGpPWpGaD
Amantadine—GRIN1—Spinal Cord Injury—CDK4—ocular cancer	0.00725	0.00725	CbGpPWpGaD
Amantadine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—ocular cancer	0.00722	0.00722	CbGpPWpGaD
Amantadine—GRIN2C—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—ocular cancer	0.00704	0.00704	CbGpPWpGaD
Amantadine—GRIN1—EPHB-mediated forward signaling—HRAS—ocular cancer	0.00687	0.00687	CbGpPWpGaD
Amantadine—GRIN1—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—ocular cancer	0.00687	0.00687	CbGpPWpGaD
Amantadine—GRIN2B—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—ocular cancer	0.0067	0.0067	CbGpPWpGaD
Amantadine—GRIN2B—EPHB-mediated forward signaling—HRAS—ocular cancer	0.0067	0.0067	CbGpPWpGaD
Amantadine—GRIN2D—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—ocular cancer	0.00655	0.00655	CbGpPWpGaD
Amantadine—GRIN2C—Alzheimers Disease—TP53—ocular cancer	0.00639	0.00639	CbGpPWpGaD
Amantadine—GRIN1—Spinal Cord Injury—RB1—ocular cancer	0.00631	0.00631	CbGpPWpGaD
Amantadine—DDC—Metabolism—PSPH—ocular cancer	0.00604	0.00604	CbGpPWpGaD
Amantadine—GRIN2D—Alzheimers Disease—TP53—ocular cancer	0.00594	0.00594	CbGpPWpGaD
Amantadine—DDC—Circadian rythm related genes—CDK4—ocular cancer	0.00551	0.00551	CbGpPWpGaD
Amantadine—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—ocular cancer	0.00538	0.00538	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—CCND3—ocular cancer	0.00537	0.00537	CbGpPWpGaD
Amantadine—GRIN2C—Transmission across Chemical Synapses—MDM2—ocular cancer	0.0053	0.0053	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—CCND3—ocular cancer	0.00523	0.00523	CbGpPWpGaD
Amantadine—MAOB—Metabolism—PSPH—ocular cancer	0.00508	0.00508	CbGpPWpGaD
Amantadine—GRIN2D—Transmission across Chemical Synapses—MDM2—ocular cancer	0.00492	0.00492	CbGpPWpGaD
Amantadine—GRIN1—Spinal Cord Injury—CDKN1B—ocular cancer	0.00491	0.00491	CbGpPWpGaD
Amantadine—GRIN2A—Alzheimers Disease—TP53—ocular cancer	0.00488	0.00488	CbGpPWpGaD
Amantadine—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—ocular cancer	0.00469	0.00469	CbGpPWpGaD
Amantadine—GRIN1—Spinal Cord Injury—CCND1—ocular cancer	0.00468	0.00468	CbGpPWpGaD
Amantadine—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—ocular cancer	0.00457	0.00457	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—E2F4—ocular cancer	0.00455	0.00455	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—RBL1—ocular cancer	0.00446	0.00446	CbGpPWpGaD
Amantadine—GRIN1—Alzheimers Disease—TP53—ocular cancer	0.00425	0.00425	CbGpPWpGaD
Amantadine—GRIN2B—Alzheimers Disease—TP53—ocular cancer	0.00415	0.00415	CbGpPWpGaD
Amantadine—GRIN2C—Neuronal System—MDM2—ocular cancer	0.00406	0.00406	CbGpPWpGaD
Amantadine—GRIN2A—Transmission across Chemical Synapses—MDM2—ocular cancer	0.00404	0.00404	CbGpPWpGaD
Amantadine—DDC—SIDS Susceptibility Pathways—EP300—ocular cancer	0.00401	0.00401	CbGpPWpGaD
Amantadine—DRD2—Circadian rythm related genes—GNA11—ocular cancer	0.00387	0.00387	CbGpPWpGaD
Amantadine—GRIN2C—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ocular cancer	0.00387	0.00387	CbGpPWpGaD
Amantadine—GRIN2D—Neuronal System—MDM2—ocular cancer	0.00377	0.00377	CbGpPWpGaD
Amantadine—GRIN1—Spinal Cord Injury—MYC—ocular cancer	0.00376	0.00376	CbGpPWpGaD
Amantadine—GRIN1—Spinal Cord Injury—TGFB1—ocular cancer	0.00375	0.00375	CbGpPWpGaD
Amantadine—DRD2—Circadian rythm related genes—GNAQ—ocular cancer	0.0036	0.0036	CbGpPWpGaD
Amantadine—GRIN2D—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ocular cancer	0.00359	0.00359	CbGpPWpGaD
Amantadine—GRIN1—EPH-Ephrin signaling—HRAS—ocular cancer	0.00354	0.00354	CbGpPWpGaD
Amantadine—GRIN1—Transmission across Chemical Synapses—MDM2—ocular cancer	0.00353	0.00353	CbGpPWpGaD
Amantadine—GRIN2B—EPH-Ephrin signaling—HRAS—ocular cancer	0.00345	0.00345	CbGpPWpGaD
Amantadine—GRIN1—SIDS Susceptibility Pathways—EP300—ocular cancer	0.00345	0.00345	CbGpPWpGaD
Amantadine—GRIN2B—Transmission across Chemical Synapses—MDM2—ocular cancer	0.00344	0.00344	CbGpPWpGaD
Amantadine—DDC—Circadian rythm related genes—EP300—ocular cancer	0.00328	0.00328	CbGpPWpGaD
Amantadine—DRD2—Circadian rythm related genes—HDAC1—ocular cancer	0.00324	0.00324	CbGpPWpGaD
Amantadine—GRIN2A—Neuronal System—MDM2—ocular cancer	0.0031	0.0031	CbGpPWpGaD
Amantadine—GRIN1—Spinal Cord Injury—TP53—ocular cancer	0.00309	0.00309	CbGpPWpGaD
Amantadine—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ocular cancer	0.00295	0.00295	CbGpPWpGaD
Amantadine—GRIN2C—Transmission across Chemical Synapses—HRAS—ocular cancer	0.00291	0.00291	CbGpPWpGaD
Amantadine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—ocular cancer	0.00282	0.00282	CbGpPWpGaD
Amantadine—GRIN1—Neuronal System—MDM2—ocular cancer	0.0027	0.0027	CbGpPWpGaD
Amantadine—GRIN2D—Transmission across Chemical Synapses—HRAS—ocular cancer	0.0027	0.0027	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—PSPH—ocular cancer	0.0027	0.0027	CbGpPWpGaD
Amantadine—GRIN2B—Neuronal System—MDM2—ocular cancer	0.00263	0.00263	CbGpPWpGaD
Amantadine—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ocular cancer	0.00257	0.00257	CbGpPWpGaD
Amantadine—GRIN1—BDNF signaling pathway—HRAS—ocular cancer	0.00252	0.00252	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—PSPH—ocular cancer	0.00251	0.00251	CbGpPWpGaD
Amantadine—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ocular cancer	0.00251	0.00251	CbGpPWpGaD
Amantadine—GRIN2B—BDNF signaling pathway—HRAS—ocular cancer	0.00245	0.00245	CbGpPWpGaD
Amantadine—DDC—Circadian rythm related genes—TP53—ocular cancer	0.00235	0.00235	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—CDK4—ocular cancer	0.00231	0.00231	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—CDK4—ocular cancer	0.00225	0.00225	CbGpPWpGaD
Amantadine—GRIN2C—Neuronal System—HRAS—ocular cancer	0.00223	0.00223	CbGpPWpGaD
Amantadine—GRIN1—BDNF signaling pathway—AKT1—ocular cancer	0.00222	0.00222	CbGpPWpGaD
Amantadine—GRIN2A—Transmission across Chemical Synapses—HRAS—ocular cancer	0.00222	0.00222	CbGpPWpGaD
Amantadine—DRD2—Circadian rythm related genes—CDK4—ocular cancer	0.00217	0.00217	CbGpPWpGaD
Amantadine—GRIN2B—BDNF signaling pathway—AKT1—ocular cancer	0.00217	0.00217	CbGpPWpGaD
Amantadine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—ocular cancer	0.00216	0.00216	CbGpPWpGaD
Amantadine—GRIN2D—Neuronal System—HRAS—ocular cancer	0.00207	0.00207	CbGpPWpGaD
Amantadine—ABCB1—HIF-1-alpha transcription factor network—EP300—ocular cancer	0.00195	0.00195	CbGpPWpGaD
Amantadine—GRIN1—Transmission across Chemical Synapses—HRAS—ocular cancer	0.00193	0.00193	CbGpPWpGaD
Amantadine—DDC—Metabolism—GNA11—ocular cancer	0.0019	0.0019	CbGpPWpGaD
Amantadine—GRIN2B—Transmission across Chemical Synapses—HRAS—ocular cancer	0.00189	0.00189	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	0.00187	0.00187	CbGpPWpGaD
Amantadine—SLC22A2—Transmission across Chemical Synapses—MDM2—ocular cancer	0.00183	0.00183	CbGpPWpGaD
Amantadine—DDC—Metabolism—GNAQ—ocular cancer	0.00177	0.00177	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	0.00172	0.00172	CbGpPWpGaD
Amantadine—SLC22A1—Transmission across Chemical Synapses—MDM2—ocular cancer	0.00171	0.00171	CbGpPWpGaD
Amantadine—GRIN2A—Neuronal System—HRAS—ocular cancer	0.0017	0.0017	CbGpPWpGaD
Amantadine—MAOB—Metabolism—GNA11—ocular cancer	0.0016	0.0016	CbGpPWpGaD
Amantadine—MAOB—Metabolism—GNAQ—ocular cancer	0.00149	0.00149	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	0.00148	0.00148	CbGpPWpGaD
Amantadine—GRIN1—Neuronal System—HRAS—ocular cancer	0.00148	0.00148	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PSPH—ocular cancer	0.00147	0.00147	CbGpPWpGaD
Amantadine—ABCB1—Allograft Rejection—TGFB1—ocular cancer	0.00147	0.00147	CbGpPWpGaD
Amantadine—GRIN2B—Neuronal System—HRAS—ocular cancer	0.00145	0.00145	CbGpPWpGaD
Amantadine—SLC22A2—Neuronal System—MDM2—ocular cancer	0.0014	0.0014	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	0.0014	0.0014	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—EP300—ocular cancer	0.00137	0.00137	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—EP300—ocular cancer	0.00134	0.00134	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—SAG—ocular cancer	0.00132	0.00132	CbGpPWpGaD
Amantadine—GRIN1—Axon guidance—HRAS—ocular cancer	0.00132	0.00132	CbGpPWpGaD
Amantadine—SLC22A1—Neuronal System—MDM2—ocular cancer	0.00131	0.00131	CbGpPWpGaD
Amantadine—DRD2—Circadian rythm related genes—EP300—ocular cancer	0.00129	0.00129	CbGpPWpGaD
Amantadine—GRIN2B—Axon guidance—HRAS—ocular cancer	0.00128	0.00128	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—TGFB1—ocular cancer	0.00119	0.00119	CbGpPWpGaD
Amantadine—ABCB1—HIF-1-alpha transcription factor network—AKT1—ocular cancer	0.00118	0.00118	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—GNA11—ocular cancer	0.00117	0.00117	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—E2F5—ocular cancer	0.00117	0.00117	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—TGFB1—ocular cancer	0.00116	0.00116	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—E2F4—ocular cancer	0.00114	0.00114	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—RBL1—ocular cancer	0.00112	0.00112	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—GNAQ—ocular cancer	0.00109	0.00109	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—GNA11—ocular cancer	0.00106	0.00106	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	0.00104	0.00104	CbGpPWpGaD
Amantadine—SLC22A2—Transmission across Chemical Synapses—HRAS—ocular cancer	0.00101	0.00101	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—GNAQ—ocular cancer	0.000986	0.000986	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—E2F3—ocular cancer	0.000972	0.000972	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.000949	0.000949	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—HRAS—ocular cancer	0.000939	0.000939	CbGpPWpGaD
Amantadine—SLC22A1—Transmission across Chemical Synapses—HRAS—ocular cancer	0.000938	0.000938	CbGpPWpGaD
Amantadine—DRD2—Circadian rythm related genes—TP53—ocular cancer	0.000925	0.000925	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—HRAS—ocular cancer	0.000915	0.000915	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.000905	0.000905	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—TFDP1—ocular cancer	0.000904	0.000904	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.000875	0.000875	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—GNA11—ocular cancer	0.000849	0.000849	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.000833	0.000833	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—AKT1—ocular cancer	0.000829	0.000829	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—AKT1—ocular cancer	0.000808	0.000808	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—GNA11—ocular cancer	0.000791	0.000791	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—GNAQ—ocular cancer	0.000789	0.000789	CbGpPWpGaD
Amantadine—SLC22A2—Neuronal System—HRAS—ocular cancer	0.000771	0.000771	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—GNAQ—ocular cancer	0.000735	0.000735	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.000726	0.000726	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.000724	0.000724	CbGpPWpGaD
Amantadine—SLC22A1—Neuronal System—HRAS—ocular cancer	0.000718	0.000718	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—MAML2—ocular cancer	0.000718	0.000718	CbGpPWpGaD
Amantadine—DDC—Metabolism—EP300—ocular cancer	0.000635	0.000635	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—GNA11—ocular cancer	0.000626	0.000626	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.000596	0.000596	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—GNAQ—ocular cancer	0.000582	0.000582	CbGpPWpGaD
Amantadine—MAOB—Metabolism—EP300—ocular cancer	0.000534	0.000534	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—HDAC1—ocular cancer	0.000525	0.000525	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.000503	0.000503	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CDKN2B—ocular cancer	0.000471	0.000471	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—GNA11—ocular cancer	0.000464	0.000464	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—E2F1—ocular cancer	0.000432	0.000432	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—GNAQ—ocular cancer	0.000431	0.000431	CbGpPWpGaD
Amantadine—DDC—Metabolism—AKT1—ocular cancer	0.000384	0.000384	CbGpPWpGaD
Amantadine—MAOB—Metabolism—AKT1—ocular cancer	0.000323	0.000323	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—EP300—ocular cancer	0.000284	0.000284	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—EP300—ocular cancer	0.000264	0.000264	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—MDM2—ocular cancer	0.000261	0.000261	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—HRAS—ocular cancer	0.000242	0.000242	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CDKN1B—ocular cancer	0.000238	0.000238	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—AKT1—ocular cancer	0.000236	0.000236	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CCND1—ocular cancer	0.000227	0.000227	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CDKN1A—ocular cancer	0.00022	0.00022	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—AKT1—ocular cancer	0.000214	0.000214	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—EP300—ocular cancer	0.000209	0.000209	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—MYC—ocular cancer	0.000182	0.000182	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—TGFB1—ocular cancer	0.000182	0.000182	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—AKT1—ocular cancer	0.000171	0.000171	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—AKT1—ocular cancer	0.00016	0.00016	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—EP300—ocular cancer	0.000155	0.000155	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—TP53—ocular cancer	0.00015	0.00015	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—HRAS—ocular cancer	0.000143	0.000143	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—AKT1—ocular cancer	0.000126	0.000126	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—AKT1—ocular cancer	9.36e-05	9.36e-05	CbGpPWpGaD
